Outsourcing-pharma3d
Verdiva Bio launches with $411m in funding to advance obesity drugs
Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an ...
Outsourcing-pharma6d
Orbis Medicines bags €90 million Series A to develop oral competitors of biologics
Orbis Medicines secures €90M Series A to develop innovative oral macrocycles, offering cost-effective alternatives to ...
Outsourcing-pharma5d
Denali Therapeutics’ ALS drug fails to improve function and survival in phase 2/3 trial
Denali Therapeutics' DNL343 fails to slow ALS progression in phase 2/3 trial but shows safety and offers insights for future ...
Outsourcing-pharma3d
India’s Anthem Biosciences plans $397m IPO
As India’s contract manufacturing and development organization (CDMO) is set to double in the next decade, Anthem Biosciences ...